These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Plk1-dependent phosphoproteome of the early mitotic spindle. Santamaria A; Wang B; Elowe S; Malik R; Zhang F; Bauer M; Schmidt A; Silljé HH; Körner R; Nigg EA Mol Cell Proteomics; 2011 Jan; 10(1):M110.004457. PubMed ID: 20860994 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions. Bibi N; Parveen Z; Rashid S PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120 [TBL] [Abstract][Full Text] [Related]
4. Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells. Cholewa BD; Pellitteri-Hahn MC; Scarlett CO; Ahmad N J Proteome Res; 2014 Nov; 13(11):5041-50. PubMed ID: 24884503 [TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus. Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Menendez JA Cell Cycle; 2011 Apr; 10(8):1295-302. PubMed ID: 21474997 [TBL] [Abstract][Full Text] [Related]
7. Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1. Raab M; Krämer A; Hehlgans S; Sanhaji M; Kurunci-Csacsko E; Dötsch C; Bug G; Ottmann O; Becker S; Pachl F; Kuster B; Strebhardt K Mol Oncol; 2015 Jan; 9(1):140-54. PubMed ID: 25169932 [TBL] [Abstract][Full Text] [Related]
8. A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation. Sharma P; Mahen R; Rossmann M; Stokes JE; Hardwick B; Huggins DJ; Emery A; Kunciw DL; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR Sci Rep; 2019 Nov; 9(1):15930. PubMed ID: 31685831 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629 [TBL] [Abstract][Full Text] [Related]
11. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain. Shin SB; Woo SU; Yim H J Cell Physiol; 2015 Dec; 230(12):3057-67. PubMed ID: 25975351 [TBL] [Abstract][Full Text] [Related]
12. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest. Chen F; Zhuo X; Qin T; Guo X; Zhang C; Lai L Chem Biol Drug Des; 2017 May; 89(5):732-740. PubMed ID: 27882722 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. Golsteyn RM; Mundt KE; Fry AM; Nigg EA J Cell Biol; 1995 Jun; 129(6):1617-28. PubMed ID: 7790358 [TBL] [Abstract][Full Text] [Related]
14. Requirements for protein phosphorylation and the kinase activity of polo-like kinase 1 (Plk1) for the kinetochore function of mitotic arrest deficiency protein 1 (Mad1). Chi YH; Haller K; Ward MD; Semmes OJ; Li Y; Jeang KT J Biol Chem; 2008 Dec; 283(51):35834-44. PubMed ID: 18922800 [TBL] [Abstract][Full Text] [Related]
15. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Sanhaji M; Kreis NN; Zimmer B; Berg T; Louwen F; Yuan J Cell Cycle; 2012 Feb; 11(3):543-53. PubMed ID: 22262171 [TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores. Ahonen LJ; Kallio MJ; Daum JR; Bolton M; Manke IA; Yaffe MB; Stukenberg PT; Gorbsky GJ Curr Biol; 2005 Jun; 15(12):1078-89. PubMed ID: 15964272 [TBL] [Abstract][Full Text] [Related]
17. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate. Lowery DM; Clauser KR; Hjerrild M; Lim D; Alexander J; Kishi K; Ong SE; Gammeltoft S; Carr SA; Yaffe MB EMBO J; 2007 May; 26(9):2262-73. PubMed ID: 17446864 [TBL] [Abstract][Full Text] [Related]
18. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Lénárt P; Petronczki M; Steegmaier M; Di Fiore B; Lipp JJ; Hoffmann M; Rettig WJ; Kraut N; Peters JM Curr Biol; 2007 Feb; 17(4):304-15. PubMed ID: 17291761 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors. Lin TY; Min HP; Jiang C; Niu MM; Yan F; Xu LL; Di B Bioorg Med Chem; 2018 Jul; 26(12):3429-3437. PubMed ID: 29807699 [TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells. Chen YJ; Lin YP; Chow LP; Lee TC Proteomics; 2011 Nov; 11(22):4331-45. PubMed ID: 21887822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]